Mayne Pharma Group Limited (ASX:MYX) Updates on Scheme of Arrangement with Cosette
Scheme of Arrangement Update
Mayne Pharma Group Limited (ASX:MYX) announced that the 10 business day consultation period asserted by Cosette Pharmaceuticals has expired without a termination notice. Cosette may still issue a termination notice before the Second Court Date, and Mayne Pharma will inform the market if this occurs.
Regulatory Developments
Mayne Pharma received a close-out letter from the FDA confirming that it has addressed the issues identified in the previously disclosed Untitled Letter.
Continued Commitment
The Board maintains that no Material Adverse Change has occurred and reserves all rights under the Scheme implementation deed. Mayne Pharma remains committed to successfully completing the Scheme and encourages shareholders to vote at the upcoming Scheme Meeting.
Motley Fool contributor Kiarra Jackson has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
This article was generated using GPT-4o mini, a Large Language Model (LLM), to generate summaries of investing news. While AI is generating the content, we know better than to blindly trust our future robot overlords, and every article is edited and fact-checked by an editor holding the appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content of everything published by The Capital Club.
